Access Cannabis Clinical Trials Cultivation Events 
Cannabis Law Report
JUNE 16, 2021
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.
NORML
OCTOBER 21, 2019
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 8, 2021
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
Cannabis Law Report
JULY 24, 2021
The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.
Cannabis Law Report
MAY 29, 2022
A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m
SpeedWeed
AUGUST 4, 2021
Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. High Times chatted with Bentley to learn more about the personal experience that caused her to be passionate about medical cannabis.
Cannabis Law Report
OCTOBER 15, 2021
Xebra Brands Ltd. (“ Xebra “), a cannabis company, is pleased to announce that it has received final approval to list its common shares on the Canadian Securities Exchange. Xebra is a cannabis company, with global brands and intellectual property. Xebra’s global brands include beverages, wellness and leisure. federally legalizes).
Expert insights. Personalized for you.
104 
Let's personalize your content